Pfizer Inc. (PFE)

AI Score

Unlock

22.32

-0.12 (-0.53%)

At close: Apr 16, 2025, 10:57 AM

Pfizer Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2024	Sep 29, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Oct 1, 2023	Jul 2, 2023	Apr 2, 2023	Dec 31, 2022	Oct 2, 2022	Jul 3, 2022	Apr 3, 2022	Dec 31, 2021	Oct 3, 2021	Jul 4, 2021	Apr 4, 2021	Dec 31, 2020	Sep 27, 2020	Jun 28, 2020	Mar 29, 2020	Dec 31, 2019	Sep 29, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jul 1, 2018	Apr 1, 2018	Dec 31, 2017	Oct 1, 2017	Jul 2, 2017	Apr 2, 2017	Dec 31, 2016	Oct 2, 2016	Jul 3, 2016	Apr 3, 2016
Revenue	17.76B	17.7B	13.28B	14.88B	14.25B	13.23B	12.73B	18.28B	24.29B	22.64B	27.74B	25.66B	23.84B	24.09B	18.98B	14.58B	11.68B	12.13B	11.8B	12.03B	12.69B	12.68B	13.26B	13.12B	13.98B	13.3B	13.47B	12.91B	13.7B	13.17B	12.9B	12.78B	13.63B	13.04B	13.15B	13.01B
Cost of Revenue	5.91B	6.58B	5.04B	4.38B	8.59B	10.6B	4.59B	6.05B	9.65B	6.06B	9.07B	9.98B	9.74B	9.97B	7.05B	4.21B	2.92B	2.53B	2.28B	2.38B	2.61B	2.6B	2.58B	2.43B	3.08B	2.69B	2.92B	2.56B	3.26B	2.85B	2.66B	2.47B	3.22B	3.08B	3.17B	2.85B
Gross Profit	11.85B	11.13B	8.24B	10.5B	5.66B	2.63B	8.14B	12.23B	14.64B	16.57B	18.68B	15.68B	14.1B	14.12B	11.93B	10.37B	8.77B	9.6B	9.52B	9.65B	10.08B	10.08B	10.69B	10.69B	10.9B	10.6B	10.55B	10.34B	10.44B	10.32B	10.23B	10.31B	10.41B	9.96B	9.97B	10.15B
Operating Income	3.19B	5.28B	1.88B	4.56B	-1.59B	-3.27B	2.08B	6.38B	6.43B	10.43B	12.95B	10.69B	4.04B	6.47B	5.31B	4.7B	-2.19B	3.33B	3.45B	4.17B	1.99B	3.32B	4.15B	4.17B	3.19B	3.85B	4.02B	3.99B	2.39B	3.38B	3.79B	4.11B	2.35B	3.55B	3.79B	4.03B
Interest Income	170M	116M	130M	129M	609M	523M	316M	177M	137M	70M	30M	14M	14M	10M	13M	n/a	4M	17M	19M	34M	41M	60M	59M	66M	93M	82M	80M	77M	117M	99M	94M	81M	113M	123M	122M	113M
Pretax Income	-10M	4.71B	-103M	3.42B	-4.13B	-3.35B	2.27B	6.27B	5.23B	9B	11.45B	9.05B	3.83B	7.84B	6.61B	5.68B	178M	2.18B	3.95B	3.88B	-1.51B	10.73B	4.14B	4.32B	-946M	4.18B	4.53B	4.13B	953M	3.58B	3.81B	3.95B	777M	1.6B	2.41B	3.56B
Net Income	410M	4.46B	24M	3.12B	-3.34B	-2.39B	2.33B	5.54B	4.99B	8.61B	9.91B	7.86B	3.39B	8.15B	5.56B	4.88B	594M	2.19B	3.49B	3.35B	-337M	7.68B	5.05B	3.88B	-394M	4.11B	3.87B	3.56B	12.27B	2.84B	3.07B	3.12B	858M	1.35B	2.05B	3.04B
Selling & General & Admin	4.27B	3.24B	3.69B	3.46B	4.48B	3.21B	3.43B	3.36B	4.64B	3.39B	2.91B	2.59B	4.1B	2.9B	2.93B	2.78B	3.76B	3.02B	3.03B	2.87B	4.24B	3.26B	3.51B	3.34B	4.01B	3.49B	3.54B	3.41B	4.55B	3.5B	3.42B	3.31B	4.42B	3.56B	3.47B	3.38B
Research & Development	3.04B	2.6B	2.68B	2.48B	2.77B	2.68B	2.63B	2.49B	3.62B	2.7B	2.81B	2.3B	5.92B	3.45B	2.46B	2.01B	3.35B	2.36B	2.13B	1.72B	2.82B	2.28B	1.84B	1.7B	2.46B	2.01B	1.8B	1.74B	2.31B	1.86B	1.78B	1.71B	2.51B	1.88B	1.75B	1.73B
Other Expenses	1.36B	n/a	230M	361M	1.03B	574M	385M	680M	1.13B	822M	-104M	835M	1.31B	1.48B	650M	658M	641M	122M	274M	318M	93M	150M	309M	420M	233M	414M	551M	127M	205M	331M	269M	176M	8M	288M	208M	309M
Operating Expenses	8.67B	5.84B	6.36B	5.94B	7.25B	5.89B	6.06B	5.85B	9.39B	6.91B	5.73B	5.73B	10.98B	7.33B	6.32B	5.67B	7.97B	6.27B	6.07B	5.48B	8.09B	6.75B	6.54B	6.22B	7.72B	6.75B	6.53B	6.35B	8.05B	6.54B	6.41B	6.2B	8.06B	6.41B	6.18B	6.12B
Interest Expense	739M	783M	778M	790M	688M	695M	508M	318M	313M	311M	293M	322M	315M	325M	316M	336M	347M	416M	372M	390M	415M	409M	389M	361M	370M	310M	326M	310M	329M	320M	312M	309M	297M	291M	292M	306M
Selling & Marketing Expenses	3.3B	n/a	n/a	n/a	3.7B	n/a	n/a	n/a	2.8B	n/a	n/a	n/a	2B	n/a	n/a	n/a	-5.9B	n/a	3.03B	2.87B	-10.11B	10.11B	n/a	n/a	3.1B	n/a	3.54B	3.41B	3.1B	3.5B	3.42B	3.31B	n/a	3.56B	3.47B	3.38B
Cost & Expenses	13.36B	12.42B	11.4B	10.32B	15.84B	16.5B	10.66B	11.9B	19.04B	12.97B	14.79B	15.71B	20.71B	17.31B	13.37B	9.88B	10.89B	8.8B	8.35B	7.86B	10.7B	9.36B	9.11B	8.66B	10.79B	9.45B	9.45B	8.91B	11.31B	9.38B	9.08B	8.67B	11.27B	9.49B	9.35B	8.97B
Income Tax Expense	-421M	234M	-134M	293M	-794M	-964M	-71M	715M	230M	356M	1.57B	1.17B	249M	-331M	1.04B	805M	-170M	-26M	519M	475M	-1.18B	3.05B	-915M	433M	-563M	66M	648M	556M	-11.34B	727M	739M	821M	13M	284M	375M	535M
Shares Outstanding (Basic)	5.67B	5.67B	5.67B	5.66B	5.65B	5.65B	5.65B	5.63B	5.62B	5.61B	5.59B	5.62B	5.62B	5.61B	5.6B	5.58B	5.56B	5.56B	5.55B	5.54B	5.54B	5.54B	5.56B	5.63B	5.79B	5.88B	5.87B	5.96B	5.96B	5.95B	5.96B	6.01B	6.07B	6.07B	6.07B	6.15B
Shares Outstanding (Diluted)	5.7B	5.71B	5.7B	5.7B	5.65B	5.65B	5.71B	5.73B	5.74B	5.72B	5.71B	5.76B	5.77B	5.72B	5.68B	5.66B	5.66B	5.63B	5.62B	5.61B	5.63B	5.65B	5.67B	5.75B	5.79B	5.99B	5.95B	6.06B	6.06B	6.04B	6.04B	6.09B	6.14B	6.14B	6.14B	6.21B
EPS (Basic)	0.07	0.79	0.00	0.55	-0.59	-0.42	0.41	0.98	0.89	1.54	1.77	1.40	0.60	1.45	0.99	0.87	0.11	0.39	0.63	0.60	-0.06	1.38	0.91	0.69	-0.07	0.70	0.66	0.60	2.06	0.48	0.52	0.52	0.13	0.22	0.33	0.49
EPS (Diluted)	0.07	0.78	0.00	0.55	-0.59	-0.42	0.41	0.97	0.87	1.51	1.73	1.37	0.59	1.42	0.98	0.86	0.10	0.39	0.62	0.60	-0.06	1.36	0.89	0.68	-0.07	0.69	0.65	0.59	2.02	0.47	0.51	0.51	0.13	0.21	0.33	0.49
EBITDA	2.52B	7.25B	2.4B	5.95B	-1.77B	-1.1B	4.35B	8.07B	7.06B	10.49B	12.91B	10.56B	5.42B	9.52B	8.61B	6.29B	-1.2B	4.47B	4.59B	4.4B	291M	12.69B	6.06B	6.23B	1.06B	6.1B	6.42B	6B	2.86B	5.47B	5.7B	5.82B	2.62B	3.29B	4.09B	5.29B
EBIT	729M	5.5B	675M	4.21B	-3.44B	-2.66B	2.78B	6.59B	5.54B	9.31B	11.74B	9.37B	4.5B	8.16B	6.92B	6.03B	-2.25B	915M	3.39B	3.23B	-1.09B	11.14B	4.53B	4.68B	-576M	4.49B	4.85B	4.44B	1.28B	3.9B	4.13B	4.26B	1.07B	1.9B	2.7B	3.87B
Depreciation & Amortization	1.79B	1.75B	1.73B	1.74B	1.67B	1.56B	1.57B	1.49B	1.52B	1.18B	1.18B	1.19B	1.28B	1.36B	1.68B	1.21B	1.05B	1.21B	1.2B	1.17B	1.38B	1.55B	1.53B	1.54B	1.25B	1.25B	1.19B	1.2B	1.19B	1.18B	1.21B	1.19B	1.12B	968M	961M	1.01B